Canaccord Genuity Lowers Illumina's Price Target to $115, Maintains 'Hold' Rating
Mar 12, 2025 17:18
CST Updated
17:18
Illumina
Diagnostic Product Developer
Gelonghui March 12 | Canaccord Genuity: Downgraded Illumina's target price from $135 to $115, maintaining a "Hold" rating. (Gelonghui)